| Bivalirudin may reduce need to use IIb/IIIa agents in ACS.(Acute coronary syndrome): An article from: Internal Medicine News | Digitalby Mitchel L. Zoler (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Thomson Gale | | Page Count: | 4 Pages | | Publication Date: | May 01, 2006 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Internal Medicine News, published by Thomson Gale on May 1, 2006. The length of the article is 974 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Bivalirudin may reduce need to use IIb/IIIa agents in ACS.(Acute coronary syndrome)Author: Mitchel L. ZolerPublication: Internal Medicine News (Magazine/Journal)Date: May 1, 2006Publisher: Thomson GaleVolume: 39 Issue: 9 Page: 44(1)Distributed by Thomson Gale |
|
